Malignant Rectal Neoplasm — Trials

Malignant Rectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,551 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 388
Recruiting: 216
Ph III recruiting: 36
Growth YoY: +12%
Industry share: 5%
Top sponsor: Fudan University
Termination share: 28%
Trials / 1,000 deaths: 30.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (153)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03623464	RCT of Mobile Apps & FitBit v. Usual Care	suspended	N/A	107	Weill Medical College of Cornell UniversityOTHER	1	Sep 28, 2026	clinicaltrials
NCT04336202	Watch and Wait Management on Rectal Cancer Patients Using New Swift Local Therapy(Whistle)	suspended	N/A	45	Sir Mortimer B. Davis - Jewish General HospitalOTHER	1	Apr 24, 2026	clinicaltrials